This week in cardiology from heartwire
View all posts »#178: Short course of aspirin, clopidogrel cuts stroke risk; Lp(a) gene variant associated with aortic stenosis; MAGELLAN published: Rivaroxaban reduces VTE risk in acutely ill patients; weight-loss drug Qsymia improves cardiovascular risk profile
Feb 15, 2013 13:25 EST-
0Comments
-
Read later
For the week ending February 15, 2013 we discuss the following top cardiology news from heartwire:
- Short course of aspirin, clopidogrel cuts stroke risk
- Lp(a) gene variant associated with aortic stenosis
- MAGELLAN published: Rivaroxaban reduces VTE risk in acutely ill patients
- Weight-loss drug Qsymia improves cardiovascular risk profile
And also, in brief:
- Community intervention improves CVD, diabetes, and cancer risk factors
- SPS3: Lower blood pressure reduces recurrent stroke
Join us for a comprehensive review of this week's most important cardiology news.
You must be a member (with full membership) to post a comment.
Already a member?
Enjoy all the benefits of theheart.org
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!












